Member Login

    
              Click here if you forgot your password.

ECA/PQG Guides

Cover of the Good Distribution Practice for Active Substances Guidance Cover if the GDP Guidance on Interpretation and Implementation

Subscribe to ECA newsletters


Members Area

Good Distribution Practice News


02/03/2017
 

What are the regulatory Definitions for "Ambient", "Room Temperature" and "Cold Chain"?

<< Back to overview <<

  

On the outer packaging of pharmaceutical products one often finds labels with storage requirements like, for example, "ambient", "room temperature" and "cold chain". But what do they exactly mean? And do these conditions also apply during transport?

The second question is easy to answer: "The required storage conditions for medicinal products should be maintained during transportation within the defined limits as described by the manufacturers or on the outer packaging." (EU GDP Guidelines). But according to the PIC/S Good Distribution Guide these conditions should also be applied for transportation (see section 9.2.1).

With the first question, it is more difficult. Here, different definitions can be found.

The European Pharmacopoeia (Pharm.Eur.) gives some hints in chapter 1.2 (Other provisions applying to general chapters and monographs) with referring to analytical procedures:

  • Deep-freeze: below -15°C;
  • Refrigerator: 2°C to 8°C;
  • Cold or cool: 8°C to 15°C;
  • Room temperature: 15°C to 25°C.

There are also some definitions in the WHO Guidance:

  • Store frozen: transported within a cold chain and stored at -20°C (4°F).
  • Store at 2°-8°C (36°-46°F): for heat sensitive products that must not be frozen.
  • Cool: Store between 8°-15°C (45°-59°F).
  • Room temperature: Store at 15°-25°C (59°-77°F).
  • Ambient temperature: Store at the surrounding temperature. This term is not widely used due to significant variation in ambient temperatures. It means "room temperature" or normal storage conditions, which means storage in a dry, clean, well ventilated area at room temperatures between 15° to 25°C (59°-77°F) or up to 30°C, depending on climatic conditions.

And the U.S. Pharmacopeia (USP) has some references.USP <659> "Packaging and Storage Requirements" gives various examples for different storage conditions, for example:

  • Cold: Any temperature not exceeding 8°C (46 °F).
  • Cool: Any temperature between 8° and 15° (46° and 59 °F)
  • Room temperature: The temperature prevailing in a work area.
  • Controlled room temperature: The temperature maintained thermostatically that encompasses at the usual and customary working environment of 20°-25° (68°-77 °F). Excursions between 15° and 30° (59° and 86 °F) that are experienced in pharmacies, hospitals, and warehouses, and during shipping are allowed. Provided the mean kinetic temperature does not exceed 25°, transient spikes up to 40° are permitted as long as they do not exceed 24 h. Spikes above 40° may be permitted only if the manufacturer so instructs.
  • Warm: Any temperature between 30° and 40°C (86° and 104 °F).
  • Excessive heat: Any temperature above 40° (104 °F).

The Japanese Pharmacopeia (JP) describes temperature for tests or storage as follows:

  • Cold: 1°C - 15°C
  • Standard temperature: 20°C
  • Ordinary temperature: 15°C - 25°C
  • Room temperature: 1°C - 30°C
  • Lukewarm: 30°C - 40°C

This is not overall harmonised, as this simple summary shows:

Pharm. Eur. WHO USP JP
Frozen/ deep-freeze >-15°C -20°C - -
Refrigerator 2°C – 8°C - - -
Cold 8°C – 15°C 2°C – 8°C <8°C 1°C – 15°C
Cool 8°C – 15°C 8°C – 15°C 8°C – 15°C -
Room temperature 15°C – 25°C 15°C – 25°C temperature prevailing in a work area 1°C – 30°C
Controlled room temperature - - 20°C – 25°C
excursions between 15°C and 30°C are allowed
-
Ambient temperature - 15°C – 25°C or 30°C depending on climatic conditions - -

And then there is the EMA GUIDELINE on DECLARATION OF STORAGE CONDITIONS from 2007, requiring that the storage conditions given in the package leaflet (PL) and the labelling of medicinal products should refer to the stability studies made for the finished product:

Testing conditions where the product is stable

Required labelling statement

Additional labelling statement, where relevant

25°C/60%RH (long term)

40°C/75%RH (accelerated)

or

30°C/65%RH (long term)

40°C/75%RH (accelerated)

None

(The following PL statement is required:

This medicinal product does not require any special storage conditions.)

Do not refrigerate or freeze

25°C/60%RH (long term)

30°C/60 or 65%RH (intermediate) or

30°C/65%RH (long term)
Do not store above 30°C or Store below 30°C

Do not refrigerate or freeze

25°C/60%RH (long term)

Do not store above 25°C or Store below 25°C

Do not refrigerate or freeze

5°C ± 3°C (long term)

Store in a refrigerator

or

store and transport refrigerated

Do not freeze

Below zero

Store in a freezer

or

store and transport frozen

 

So, as a resume,  terms like "ambient", "room temperature" and "cold chain" should be avoided as the only labelling for storage or transport boxes and containers because they are not always clear and might have different meanings in other parts of the world. Storage conditions are always better explicitly specified in terms of a defined temperature range (e.g., 15°C -25°C or +2°C to +8°C). Particular attention should be given to avoiding freezing of liquids and semi-solids.


 

Conference Recommendations

<< Back to overview <<